OBJECTIVE: To investigate the prognostic significance of symptomatic primary HIV-1 infection. DESIGN: Prospective study of homosexual men seroconverting to HIV in 1985 and 1986. Patients were followed up at least three times yearly with clinical examinations and T cell subset determinations for an average of 7.2 years. SETTING: Research project centred on attenders for treatment and screening for HIV at the Karolinska Institute, Stockholm. SUBJECTS: 19 patients presenting with a glandular-fever-like illness associated with seroconversion to HIV and 29 asymptomatic seroconverters. MAIN OUTCOME MEASURES: Progression to Centers for Disease Control and Prevention stage IV disease, CD4 cell count below 200 x 10(6)/l, AIDS, and death from AIDS. RESULTS: Symptomatic seroconverters were significantly more likely to develop Centers for Disease Control and Prevention stage IV disease (95% v 66%), CD4 cell counts below 200 x 10(6)/l (84% v 55%), and AIDS (58% v 28%) and die of AIDS (53% v 7%). CONCLUSION: A glandular-fever-like illness associated with seroconversion to HIV-1 predicts accelerated progression to AIDS and other HIV related diseases.
OBJECTIVE: To investigate the prognostic significance of symptomatic primary HIV-1 infection. DESIGN: Prospective study of homosexual men seroconverting to HIV in 1985 and 1986. Patients were followed up at least three times yearly with clinical examinations and T cell subset determinations for an average of 7.2 years. SETTING: Research project centred on attenders for treatment and screening for HIV at the Karolinska Institute, Stockholm. SUBJECTS: 19 patients presenting with a glandular-fever-like illness associated with seroconversion to HIV and 29 asymptomatic seroconverters. MAIN OUTCOME MEASURES: Progression to Centers for Disease Control and Prevention stage IV disease, CD4 cell count below 200 x 10(6)/l, AIDS, and death from AIDS. RESULTS: Symptomatic seroconverters were significantly more likely to develop Centers for Disease Control and Prevention stage IV disease (95% v 66%), CD4 cell counts below 200 x 10(6)/l (84% v 55%), and AIDS (58% v 28%) and die of AIDS (53% v 7%). CONCLUSION: A glandular-fever-like illness associated with seroconversion to HIV-1 predicts accelerated progression to AIDS and other HIV related diseases.
Authors: J Learmont; B Tindall; L Evans; A Cunningham; P Cunningham; J Wells; R Penny; J Kaldor; D A Cooper Journal: Lancet Date: 1992-10-10 Impact factor: 79.321
Authors: J Albert; H Gaines; A Sönnerborg; G Nyström; P O Pehrson; F Chiodi; M von Sydow; L Moberg; K Lidman; B Christensson Journal: J Med Virol Date: 1987-09 Impact factor: 2.327
Authors: H Gaines; M von Sydow; A Sönnerborg; J Albert; J Czajkowski; P O Pehrson; F Chiodi; L Moberg; E M Fenyö; B Asjö Journal: Lancet Date: 1987-05-30 Impact factor: 79.321
Authors: D A Cooper; J Gold; P Maclean; B Donovan; R Finlayson; T G Barnes; H M Michelmore; P Brooke; R Penny Journal: Lancet Date: 1985-03-09 Impact factor: 79.321
Authors: H Gaines; M von Sydow; J V Parry; M Forsgren; P O Pehrson; A Sönnerborg; P P Mortimer; O Strannegård Journal: AIDS Date: 1988-02 Impact factor: 4.177
Authors: Philip J Norris; Brandee L Pappalardo; Brian Custer; Gerald Spotts; Frederick M Hecht; Michael P Busch Journal: AIDS Res Hum Retroviruses Date: 2006-08 Impact factor: 2.205
Authors: Trevor A Crowell; Donn J Colby; Suteeraporn Pinyakorn; James L K Fletcher; Eugène Kroon; Alexandra Schuetz; Shelly J Krebs; Bonnie M Slike; Louise Leyre; Nicolas Chomont; Linda L Jagodzinski; Irini Sereti; Netanya S Utay; Robin Dewar; Rungsun Rerknimitr; Nitiya Chomchey; Rapee Trichavaroj; Victor G Valcour; Serena Spudich; Nelson L Michael; Merlin L Robb; Nittaya Phanuphak; Jintanat Ananworanich Journal: Clin Infect Dis Date: 2018-05-02 Impact factor: 9.079
Authors: V Sanchez-Merino; A Fabra-Garcia; N Gonzalez; D Nicolas; A Merino-Mansilla; C Manzardo; J Ambrosioni; A Schultz; A Meyerhans; J R Mascola; J M Gatell; J Alcami; J M Miro; E Yuste Journal: J Virol Date: 2016-05-12 Impact factor: 5.103